Injury-related production of cysteinyl leukotrienes contributes to brain damage following experimental traumatic brain injury

Journal of Neurotrauma

Volumn 26, Issue 11, 2009, Pages 1977-1986

  Farias, Santiago ^a,b   Frey, Lauren C ^b,c   Murphy, Robert C ^a,b   Heidenreich, Kim A ^a,b,d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Eastern Colorado Health Care System ^*  (United States)

^d Eastern Colorado Health Care System   (United States)

Author keywords

Cysteinyl leukotrienes; Inflammation; Mass spectrometry; Traumatic brain injury

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; LEUKOTRIENE; LEUKOTRIENE C4; LEUKOTRIENE D4; PEPTIDOLEUKOTRIENE; VINBLASTINE SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; BLOOD BRAIN BARRIER; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; IMMUNE SYSTEM; INFLAMMATION; LIPID ANALYSIS; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NEUTROPHIL; NONHUMAN; RAT; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CHROMATOGRAPHY, LIQUID; CYSTEINE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; INDOLES; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENES; MALE; MASS SPECTROMETRY; NEUTROPHILS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 75449085760     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2009.0877     Document Type: Article

References (54)

1. Baba, T., Black, K.L., Ikezaki, K., Chen, K.N., and Becker, D.P. (1991). Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats. J. Cereb. Blood Flow Metab. 11, 638-643.
2. Ballerini, P., Di Iori, P., Cicarelli, R., Caciagli, F., Poli, A., Beraudi, A., Buccella, S., D'Alimonte, I., D'Auro, M., Nargi, E., Patricelli, P., Visini, D., and Traversa, U. (2005). P2Y1 and cysteinyl leukotriene receptor mediate purine and cysteinyl lukoriene co-release in primary cultures of rat microglia. Int. J. Immunopathol. Pharmacol. 18, 255-268.
3. Beray-Berthat, V., Croci, N., Plotkine, M., and Margaill, I. (2003). Polymorphonuclear neutrophils contribute to infarction and oxidative stress in the cortex but not in the striatum after ischemia-reperfusion in rats. Brain Res. 987, 32-38. (Pubitemid 37267884)
4. Borgeat, P., and Samuelsson, B. (1979). Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds. J. Biol. Chem. 254, 7865-7869.
5. Boyce, J.A. (2005). Eicosanoid mediators of mast cells: receptors, regulation of synthesis, and pathobiologic implications. Chem. Immunol. Allergy 87, 59-79.
6. Busse, W., and Kraft, M. (2005). Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest 127, 1312-1326.
7. Capra, V. (2004). Molecular and functional aspects of human cysteinyl leukotriene receptors. Pharmacol. Res. 50, 1-11.
8. Chiamulera, C., Terron, A., Reggiani, A., and Cristofori, P. (1993). Qualitative and quantitative analysis of the progressive cerebral damage after middle cerebral artery occlusion in mice. Brain Res. 606, 251-258.
9. Ciceri, P., Rabuffetti, M., Monopoli, A., and Nicosia, S. (2001). Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br. J. Pharmacol. 133, 1323-1329.
10. Deutsch, J., Rapoport, S.I., and Purdon, A.D. (1997). Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation. Neurochem. Res. 22, 759-765.
11. Dhillon, H.S., Dose, J.M., and Prasad, M.R. (1996). Regional generation of leukotriene C4 after experimental brain injury in anesthetized rats. J. Neurotrauma 13, 781-789.
12. Evans, J.F., Ferguson, A.D., Mosley, R.T., and Hutchinson, J.H. (2008). What's all the FLAP about? 5-lipoxygenase-activating protein inhibitors for inflammatory diseases. Trends Pharmacol. Sci. 29, 72-78.
13. Farias, S.E., Basselin, M., Chang, L., Heidenreich, K.A., Rapoport, S.I., and Murphy, R.C. (2008). Formation of eicosanoids, E2=D2 isoprostanes, and docosanoids following decapitationinduced ischemia, measured in high-energy-microwaved rat brain. J. Lipid Res. 49, 1990-2000.
14. Farias, S.E., Zarini, S., Precht, T., Murphy, R.C., and Heidenreich, K.A. (2007). Transcellular biosynthesis of cysteinyl leukotrienes in rat neuronal and glial cells. J. Neurochem. 103, 1310-1318. (Pubitemid 47631801)
15. Feldmann, H., Klages, G., Gärtner, F., and Scharfenberg, J. (1979). The prognostic value of intracranial pressure monitoring after severe head injuries. Acta Neurochir. Suppl (Wien) 28, 74-77.
16. Fiala, J.C. (2005). Reconstruct: a free editor for serial section microscopy. J.Microscopy 218:52-61. http:==fiala-fantoccini.com= resources=jmi-1466.pdf.
17. Finkelstein, E., Corso P., Miller, T., et al. (2006). The Incidence and Economic Burden of Injuries. Oxford University: New York.
18. Fisher, H. (2008). U.S. Military Casualty Statistics: Operation Iraqi Freedom and Operation Enduring Freedom. CRS Report for Congress. Washington, D.C.
19. Frey, L.C., Hellier, J., Unkart, C., Lepkin, A., Howard, A., Hasebroock, K., Serkova, N., Liang, L., Patel, M., Soltesz, I., and Staley, K. (2009). A novel apparatus for lateral fluid percussion injury in the rat. J. Neurosci. Methods 177, 267-272.
20. Fujimoto, S.T., Longhi, L., Saatman, K., Conte, V., Stocchetti, N., and McIntosh, T.K. (2004). Motor and cognitive function evaluation following experimental traumatic brain injury. Neurosci. Biobehav. Rev. 28, 365-378.
21. Goldlust, E.J., Paczynski, R.P., He, Y.Y., Hsu, C.Y., and Goldberg, M.P. (1996). Automated measurement of infarct size with scanned images of triphelnyl chloride-stained rat brain. Stroke 27, 1657-1662.
22. Guhlmann, A., Keppler, A., Kästner, S., Krieter, H., Brückner, U.B., Messmer, K., and Keppler, D. (1989). Prevention of endogenous leukotriene production during anaphylaxis in the guinea pig by an inhibitor of leukotriene biosynthesis (MK-886) but not by dexamethasone. J. Exp. Med. 170, 1905-1918.
23. Haeggstrom, J.Z. (2004). Leukotriene A4 hydrolase/ aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis. J. Biol. Chem. 279, 50639-50642.
24. Hall, L.M., and Murphy, R.C. (1998). Electrospray mass spectrometric analysis of 5-hydroperoxy and 5-hydroxyeicosatetraenoic acids generated by lipid peroxidation of red blood cell ghost phospholipids. J. Am. Soc. Mass Spectrom. 9, 527-532.
25. Hu, H., Chen, G., Zhang, J.M., Zhang, W.P., Zhang, L., Ge, Q.F., Yao, H.T., Ding, W., Chen, Z., and Wei, E.Q. (2005). Distribution of cysteinyl leukotriene receptor 2 in human traumatic brain injury and brain tumors. Acta Pharmacol. Sin. 26, 685-690.
26. Jatana, M., Giri, S., Ansari, M.A., Elango, C., Singh, A.K., Singh, I., and Khan, M. (2006). Inhibition of NF-kappaB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia. J. Neuroinflammation 11, 3-12.
27. Kitagawa, K., Matsumoto, M., and Hori, M. (2004). Cerebral ischemia in 5-lipoxygenase knockout mice. Brain Res. 1004, 198-202.
28. Lam, B.K. (2003). Leukotriene C4 synthase. Prostaglandins Leukot. Essent. Fatty Acids 69, 111-116.
29. Langois, J.A., Rutland-Brown, W., and Thomas, K.E. (2006). Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Atlanta.
30. Leslie, C.C. (2004). Regulation of the specific release of arachidonic acid by phospholipase A2. Prostaglandins Leukot. Essent. Fatty Acids 70, 373-376.
31. Levin, H.S. (1995). Prediction of recovery from traumatic brain injury. J. Neurotrauma 12, 913-922.
32. Lewis, R.A., Austen, K.F., and Soberman, R.J. (1990). Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 10, 645-655.
33. Luo, M., Jones, S.M., Peters-Golden, M., and Brock, T.G. (2003). Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity. Proc. Natl. Acad. Sci. USA 100, 12165-12170.
34. Lynch, K.R., O'Neill, G.P., Liu, Q., Im, D.S., Sawyer, N., Metters, K.M., Coulombe, N., Abramovitz, M., Figueroa, D.J., Zeng, Z., Connolly, B.M., Bai C, Austin, C.P., Chateauneuf, A., Stocco, R., Greig, G.M., Kargman, S., Hooks, S.B., Hosfield, E., Williams, D.L., Jr., Ford-Hutchinson, A.W., Caskey, C.T., and Evans, J.F. (1999). Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399, 789-789
35. Maekawa, A., Kanaoka, Y., Xing, W., and Austen, K.F. (2008). Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors. Proc. Natl. Acad. Sci. USA 105, 16695-16700.
36. Marmarou, A. (2007). A review of progress in understanding the pathophysiology and treatment of brain edema. Neurosurg. Focus 22, E1.
37. Murphy, R.C., and Gijon, M.A. (2007). Biosynthesis and metabolism of leukotrienes. J. Biochemistry 405, 379-395.
38. Nothacker, H.P., Wang, Z., Zhu, Y., Reinscheid, R.K., Lin, S.H., and Civelli, O. (2000). Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. Mol. Pharmacol. 58, 1601-1608.
39. Palmblad, J., Gyllenhammar, H., Lindgren, J.A., and Malmsten, C.L. (1984). Effects of leukotrienes and f-Met-Leu-Phe on oxidative metabolism of neutrophils and eosinophils. J. Immunol. 6, 3041-3045.
40. Perri, B.R., Smith, D.H., Murai, H., Sinson, G., Saatman, K.E., Raghupathi, R., Bartus, R.T., and McIntosh, T.K. (1997). Metabolic quantification of lesion volume following experimental traumatic brain injury in the rat. J. Neurotrauma 14, 15-22.
41. Phillis, J.W., and O'Regan, M.H. (2003). The role of phospholipases, cyclooxygenases, and lipoxygenases in cerebral ischemic/ traumatic injuries. Crit. Rev. Neurobiol. 15, 61-90.
42. Provost, P., Borgeat, P., and Merhi, Y. (1998). Platelets, neutrophils, and vasoconstriction after arterial injury by angioplasty in pigs: effects of MK-886, a leukotriene biosynthesis inhibitor. Br. J. Pharmacol. 123, 251-258.
43. Rao, A.M., Hatcher, J.F., Kindy, M.S., and Dempsey, R.J. (1999) Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem. Res. 24, 1225-1232.
44. Rouzer, C.A., Matsumoto, T., Shimizu, T., and Samuelsson, B. (1986). The human leukocyte 5-lipoxygenase: enzyme purification, multi-component regulatory system, and LTA4 synthase activity.Adv. Prostaglandin Thromboxane Leukot. Res. 16, 3-16.
45. Sarau, H.M., Ames, R.S., Chambers, J., Ellis, C., Elshourbagy, N., Foley, J.J., Schmidt, D.B., Muccitelli, R.M., Jenkins, O., Murdock, P.R., Herrity N.C., Halsey, W., Sathe, G., Muir, A.I., Nuthulaganti, P., Dytko, G.M., Buckley, P.T., Wilson, S., Bergsma, D.J., and Hay, DW. (1999). Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol. Pharmacol. 56, 657-663.
46. Schallert, T. (2006). Behavioral tests for preclinical intervention assessment. NeuroRx 3, 497-504.
47. Schuhmann, M.U., Mokhtarzadeh, M., Stichtenoth, D.O., Skardelly, M., Klinge, P.M., Gutzki, F.M., Samii, M., and Brinker, T. (2003). Temporal profiles of cerebrospinal fluid leukotrienes, brain edema and inflammatory response following experimental brain injury. Neurol. Res. 25, 481-491.
48. Soares, H.D., Hicks, R.R., Smith, D., and McIntosh, T.K. (1995). Inflammatory leukocyte recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J. Neuroscience 15, 8223-8233.
49. Thurman, D.J., Alverson, C., Dunn, K.A., Guerrero, J., and Sniezek, J.E. (1999). Traumatic brain injury in the United States: a public health perspective. J. Head Trauma Rehabil. 14, 602-615.
50. Uz, T., Dimitrijevic, N., Imbesi, M., Manev, H., and Manev, R. (2008). Effects of MK-886, a 5-lipoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice. Neurosci Lett. 436, 269-272.
51. Wang, M.L., Huang, X.J., Fang, S.H., Yuan, Y.M., Zhang, W.P., Lu, Y.B., Ding, Q., and Wei, E.Q. (2006). Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression. Biochem. Biophys. Res. Commun. 350, 399-404.
52. Warden, D.L., Ryan, L.M., Helmick, K.M., et al. (2005).War neurotrauma: the Defense and Veterans Brain Injury Center (DVBIC) experience at Walter Reed Army Medical Center (WRAMC). J. Neurotrauma 22, 1178.
53. Yu, G.-L., Wei, E.-Q., Zhang, S.-H., Xu, H.-M., Chu, L.-S., Zhang, W.-P., Chen, Z., Mei, R.-H., and Zhao, M.-H. (2005). Montelukast, a cysteinyl leukotriene receptor-1 antagonist, doseand time-dependently protects against focal cerebral ischemia in mice. Pharmacology 73, 31-40. (Pubitemid 39664219)
54. Zhang, W.P., Hu, H., Zhang, L., Ding, W., Yao, H.T., Chen, K.D., Sheng, W.W., Chen, Z., and Wei, E.Q. (2004). Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors. Neurosci. Lett. 17, 247-251.